Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -57,943 | -4,687 | -2,009 | -5,339 | -4,250 |
| Depreciation Amortization | 11 | 31 | 19 | 111 | 88 |
| Accounts payable and accrued liabilities | 7,978 | 209 | 167 | 28 | -12 |
| Other Working Capital | 7,611 | 268 | 348 | -472 | -341 |
| Other Operating Activity | 3,324 | 17 | -53 | 658 | 557 |
| Operating Cash Flow | $-39,019 | $-4,162 | $-1,528 | $-5,014 | $-3,958 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -171 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-171 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 24,980 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 14 | N/A | N/A | N/A |
| Other Financing Activity | 425,085 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $450,065 | $14 | $N/A | $N/A | $N/A |
| Beginning Cash Position | N/A | 37,431 | 37,431 | 42,445 | 42,445 |
| End Cash Position | 410,875 | 33,283 | 35,903 | 37,431 | 38,487 |
| Net Cash Flow | $410,875 | $-4,148 | $-1,528 | $-5,014 | $-3,958 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,019 | -4,162 | -1,528 | -5,014 | -3,958 |
| Capital Expenditure | -171 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -39,190 | -4,162 | -1,528 | -5,014 | -3,958 |